SOURCE: WayPoint Biomedical, Inc.

December 08, 2005 06:30 ET

WayPoint Biomedical Featured on MacReport.Net

HUNTINGTON BEACH, CA -- (MARKET WIRE) -- December 8, 2005 -- WayPoint Biomedical, Inc. (OTC: WYPH) announced today that WayPoint CEO, Dennis Shepherd and WYPH are featured on the MacReport.Net, a leading provider of online business and financial information. “The MacReport.Net is a powerful tool that will allow WYPH to increase its presence with investors and the Wall Street community,” stated Mr. Shepherd.

The MacReport.Net is a financial services network that takes a 3-dimensional approach to disseminate information and increase exposure to the Wall Street community, as well as potential investors. The MacReport.Net distributes releases through traditional channels, makes contacts and provides these releases to thousands of qualified investors and provides its members with their own unique interactive audio page within the MacReport.Net’s heavily trafficked website. Mr. Shepherd noted, “As WYPH continues to move forward the ability to get information out to our investors and to new potential investors is paramount. This opportunity allows investors not only to read about WYPH, but truly connect with us by seeing and hearing who we are and what WYPH’s vision of the future is. This technology has taken WYPH’s ability to distribute information to an exciting new level and stay ahead of the curve in the highly competitive investment market.”

Existing shareholders or potential investors can track news and updates on WYPH by registering online at www.macreport.net. Registered users can also submit requests for additional information or ask questions regarding WYPH or any member company through the MacReport.Net site.

About WayPoint Biomedical:

WayPoint Biomedical, Inc., a wholly owned subsidiary of WayPoint Biomedical Holdings, Inc. (OTC: WYPH), is an innovative biomedical technology firm, specializing in diagnostic tests and devices for screening and monitoring human health, fitness and environment. The Company develops and markets cutting-edge disposable rapid tests that offer both a preliminary diagnostic screen to specific conditions, along with a future path for consumers, medical providers, and first responders to follow regarding their health status or environmental condition. WayPoint’s unique and affordable home-based and on-site tests are focused on detecting the cause of a disease or pathogen, as opposed to determining the symptom; becoming a part of the solution to help reverse the escalating cost of Healthcare. The Company’s primary target sectors are the Over the Counter (OTC) Self-Testing Market, the Diagnostic Point of Care (POC) Testing Market, and the Homeland Security & Defense Market; three of the fastest growing areas in all of diagnostic medicine and science. For more information on WayPoint Biomedical visit www.waypointbiomedical.com, www.drinkdetectiveusa.com.

This news release may include comments that do not refer strictly to historical results or actions and may be deemed to be forward-looking within the meaning of the safe harbor provisions of the U.S. federal securities laws. These include, among other things, statements about expectations of future business, revenues, cash flows and capital requirements. Forward-looking statements are subject to risks and uncertainties that may cause the company's results to differ materially from expectations. These risks include the company's ability to further develop its business, the company's ability to generate revenues, develop appropriate strategic alliances and successful development and implementation of technology, acceptance of the company's services, competitive factors, new products and technological changes, and other such risks as the company may identify and discuss from time to time, including those risks disclosed in the company's amended registration statement on Form SB-2 filed with the Securities and Exchange Commission. Accordingly, there is no certainty that the company's plans will be achieved.

Contact Information